Search

everythinglearnresearchcommunity

for

Search:↓

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Skin may help in getting rid of excess iron through the process of skin cell renewal.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Looking at tissue characteristics isn't reliable for telling apart basal cell carcinoma from certain benign skin tumors.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Sema3A can both slow and speed up wound healing, depending on its form and combination with EGF.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Laser hair removal may cause skin changes that prevent hair regrowth.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Lower SMAD2/3 activation predicts more severe skin cancer.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

The new AI software predicts melanoma outcomes more accurately than traditional methods.

The dog recovered well from skin cancer and intestinal blockage after treatment.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.